Stockscreener 앱 받기
0.7053
1.88%
0.013
시간 외 거래:
.71
0.0047
+0.67%
전일 마감가:
$0.6923
열려 있는:
$0.68
하루 거래량:
95,446
Relative Volume:
0.55
시가총액:
$45.40M
수익:
$64.42M
순이익/손실:
$-73.78M
주가수익비율:
-
EPS:
-
순현금흐름:
$-60.50M
1주 성능:
-8.34%
1개월 성능:
+0.04%
6개월 성능:
-69.33%
1년 성능:
-84.40%
1일 변동 폭
$0.68
$0.7329
1주일 범위
$0.68
$0.7876
52주 변동 폭
$0.5535
$4.64
Allurion Technologies Inc Stock (ALUR) Company Profile
명칭
Allurion Technologies Inc
전화
508-647-4000
주소
11 HURON DR STE 200, NATICK
Allurion Technologies Inc 주식(ALUR)의 최신 뉴스
Allurion reports significant weight loss in global patient study By Investing.com - Investing.com Australia
Allurion reports significant weight loss in global patient study - Investing.com
Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference - Business Wire
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024 - Marketscreener.com
Allurion sets date for first annual stockholders meeting By Investing.com - Investing.com Canada
Allurion sets date for first annual stockholders meeting - Investing.com
Allurion Technologies : Proxy Statement Form 8 K - Marketscreener.com
Allurion Technologies, Inc. Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com
RTW INVESTMENTS, LP Reduces Stake in Allurion Technologies Inc - GuruFocus.com
ALUR Stock Declines Despite Submitting PMA for Allurion Balloon - Yahoo Finance
Allurion Technologies (NYSE:ALUR) Shares Down 3.8% – Time to Sell? - Defense World
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com
Allurion reports weight loss success with gastric balloon By Investing.com - Investing.com South Africa
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks - Benzinga
Allurion’s swallowable balloon hits trial success amid weakening financials - Yahoo! Voices
Allurion reports weight loss success with gastric balloon - Investing.com India
Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss - Marketscreener.com
Allurion Technologies Inc (ALUR-N) QuotePress Release - The Globe and Mail
ALUR Stock Update: Allurion Technologies Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
TD Cowen Initiates Coverage of Allurion Technologies (ALUR) with Buy Recommendation - Nasdaq
PHLX Swiss Franc (XDS) QuotePress Release - The Globe and Mail
U.S. Dollar Index (DXY) QuotePress Release - The Globe and Mail
S&P 500 Index (INX) QuotePress Release - The Globe and Mail
S&P 500 Industrials [Sector] (SRIN) QuotePress Release - The Globe and Mail
S&P 500 Utilities [Sector] (SRUT) QuotePress Release - The Globe and Mail
TD Cowen Begins Coverage on Allurion Technologies (NYSE:ALUR) - Defense World
Allurion reports average 12.5% weight loss in latest study - Investing.com
Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss - Marketscreener.com
CVI Holdings LLC Invests $520,000 in Allurion Technologies Inc. (NYSE:ALUR) - Defense World
Certain Common Stock of Allurion Technologies Inc. are subject to a Lock-Up Agreement Ending on 27-SEP-2024. - Marketscreener.com
Keith Johns Joins Allurion's Board Of Directors - MPO-mag
Keith Johns Joins Allurion’s Board of Directors - MPO-mag
Allurion stock soars 85% on weight-loss product launch - MSN
Allurion Technologies Inc. (NYSE:ALUR) Short Interest Up 8.6% in August - Defense World
Adrian Wild Named To Allurion's Senior Management Team - MPO-mag
Financial Snapshot: Analyzing Allurion Technologies Inc (ALUR)’s Key Ratio Metrics - The Dwinnex
Roth Mkm Initiates Coverage on Allurion Technologies (NYSE:ALUR) - Defense World
Roth Capital Upgrades Allurion Technologies (NYSE:ALUR) to “Strong-Buy” - Defense World
Allurion Technologies Inc: Navigating Market Fluctuations with a 53.28M Market Cap - The InvestChronicle
Roth/MKM bullish on Allurion stock, cites U.S. approval opportunity for weight-loss balloon - Investing.com Canada
Allurion Receives Continued Listing Standards Notice from NYSE - Marketscreener.com
Allurion Technologies Faces NYSE Compliance Hurdle - TipRanks
Allurion’s swallowable balloon leads to 13% weight reduction in teens - Yahoo Finance
Allurion reports safe weight loss in teens with new balloon program - Investing.com Canada
Allurion Unveils Safety Report - Baystreet.ca
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity - The Bakersfield Californian
Allurion Technologies Appoints New Class III Director - TipRanks
Allurion Appoints Keith Johns to Its Board of Directors - citybiz
Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors - Business Wire
Wall Street analysts’ outlook for Allurion Technologies Inc (ALUR) - SETE News
Market Highlights: Allurion Technologies Inc (ALUR) Ends on a Low Note at 0.66 - The Dwinnex
Allurion Technologies Inc (ALUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
1.00%
자본화:
|
볼륨(24시간):